Las Vegas, NV -- (SBWIRE) -- 10/05/2013 -- EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more .EquityObserver.com issues a special report on the following stocks: UnitedHealth Group Inc. (NYSE:UNH), Rexahn Pharmaceuticals, Inc. (NYSEMKT: RNN), AbbVie Inc (NYSE:ABBV), Mast Therapeutics Inc (NYSEMKT: MSTX)
UnitedHealth Group Inc. (NYSE:UNH) managed to keep its gain at 0.65% on below -normal volume of 4.30M shares. The stock settled at $72.99 after floating in a range of $72.23 to $73.14. Its latest price has reached market capitalization of $74.21 billion. Its 52-week range has been $51.09 to $75.88. UnitedHealth Group Incorporated operates as a diversified health and well-being company in the United States.
For How Long UNH will fight for Profitability? Read This Trend Analysis report
Rexahn Pharmaceuticals, Inc. (NYSEMKT: RNN) traded down on a volume of 4.14 million, higher than its standard daily volume. Shares have gained 3.96% to $0.525. Over the last twelve months, the stock has gained 3.96% and faced a worst price of $0.28.\ Rexahn Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, engages in the discovery, development, and commercialization of treatments for cancer, central nervous system disorders, sexual dysfunction, and other medical needs.
For How Long RNN’s Gloss will Attract Investors? Find out via this report
AbbVie Inc (NYSE:ABBV) settled 1.72% higher at $46.80 on below -normal volume of 4.14M shares during the last trading day. The stock has its 12-month high at $48.42 and 52-week low price was $35.51. It traded in a range of $46. to $46.88 during the last trading day. AbbVie Inc., a research-based biopharmaceutical company, engages in the discovery, development, manufacture, and sale of pharmaceutical products worldwide.
Why Should Investors Buy ABBV After the Recent Fall? Just Go Here and Find Out
In the last trading session, Mast Therapeutics Inc (NYSEMKT: MSTX) was up on high volume, trading at a volume of 3.83M versus its average daily volume of 1.28 million shares. At $0.498, the stock has attained market capitalization of 51.10 billion. Mast Therapeutics, Inc., a biopharmaceutical company, focuses on developing therapies for serious or life-threatening diseases.
Will MSTX Continue To Move Higher? Find Out Here
About Equity Observer
Equity Observer delivers intra-day insights into the equities, tech and investment world. The website is a window into what’s going on in the business world and why.
EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more.
The disclaimer is to be read and fully understood before using our site, or joining our email list.
http://www.equityobserver.com/ has a no tolerance spam policy; we will not sell or re-distribute your email to any 3rd party. A If applicable, please also unsubscribe from the newsletter using the link at the bottom of the email if you no longer wish to receive our emails. We only send our newsletters to opt-in members.
PLEASE NOTE WELL: The http://www.equityobserver.com/" rel="nofollow" href="http://www.equityobserver.com/"> http://www.equityobserver.com/>
Employees and contributors are NOT registered as an Investment Adviser in any jurisdiction whatsoever.
Read Full Disclaimerat: http://www.equityobserver.com/
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)